NDC 43598-560-79 - Lansoprazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-560
- Requested NDC
- 43598-560-79
- Package NDCs from labels
- 43598-560-79, 43598-560-78
- Manufacturer
- Dr.Reddys Laboratories Inc | DR. REDDY'S LABORATORIES LIMITED (FTO-Sez-Process Unit-01)
- Effective date
- 2024-06-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lansoprazole - Dr.Reddys Laboratories Inc | DR. REDDY'S LABORATORIES LIMITED (FTO-Sez-Process Unit-01) | Dr.Reddys Laboratories Inc | DR. REDDY'S LABORATORIES LIMITED (FTO-Sez-Process Unit-01) | 2024-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-560-78 | Lansoprazole | 100 in 1 CARTON | TABLET, ORALLY DISINTEGRATING, D | 100 | 11 | |
| 43598-560-79 | Lansoprazole | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING, D | 10 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-560-78 | EA - Each | 43598-560 | 4d5297de-6ce0-437d-a6ca-7ebdc6a7df2f | 1 | 2021-03-02 |
| 43598-560-79 | EA - Each | 43598-560 | e6913449-db90-464a-8fc1-ca97e9cf5a30 | 1 | 2022-04-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL | |
| Lansoprazole | LANSOPRAZOLE | Proficient Rx LP | 3e3e63df-e2ad-420b-acb9-28e65ea6fb07 | 2022-10-01 | Warnings, Adverse reactions | 0K5C5T2QPG |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| LANSOPRAZOLE | LANSOPRAZOLE | Zydus Pharmaceuticals USA Inc. | 9b3869ad-f2f7-4954-b75c-5c23b8951635 | 2022-08-22 | Warnings, Adverse reactions | 351260 351261 0K5C5T2QPG |
| Magnesia Carbonica | MAGNESIA CARBONICA | Hahnemann Laboratories, INC. | e4310548-b362-a2c6-e053-2a95a90ac607 | 2022-07-19 | 0E53J927NA | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
| Lansoprazole | LANSOPRAZOLE | BluePoint Laboratories | 924c5a35-4804-4e14-a2fc-2b84d186d257 | 2022-06-20 | Warnings, Adverse reactions | 0K5C5T2QPG |
| Lansoprazole | LANSOPRAZOLE | Teva Pharmaceuticals USA, Inc. | 6b8dd0e1-cd69-4f9a-887f-e42627b5d78e | 2022-04-29 | Warnings, Adverse reactions | 351260 351261 0K5C5T2QPG |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL | |
| Lansoprazole | LANSOPRAZOLE | Xiromed LLC | 00a574e0-bd03-deea-9f85-b108f78982ba | 2022-04-15 | Warnings, Adverse reactions | 0K5C5T2QPG |
| Lansoprazole | LANSOPRAZOLE | Dr.Reddy's Laboratories Ltd. | 82174fcc-1b0f-2068-7fc4-db335b43b5e2 | 2022-03-21 | Warnings, Adverse reactions | 0K5C5T2QPG |
| Lansoprazole | LANSOPRAZOLE | Teva Pharmaceuticals USA, Inc. | 427cf924-be17-47dc-8f77-115fa2f3fe17 | 2022-03-01 | Warnings, Adverse reactions | 0K5C5T2QPG |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| TH-101 | CALC CARB, CARBO VEG, CHELIDONIUM MAJ, COQ10, FUCUS, GRAPHITES, HOMEOPATHIC GLYCOPROTEIN COMPLEX, HYPOTHALAMUS, KALI PHOS, LYCOPODIUM, MAG PHOS, NAT MUR, NAT PHOS, NUX VOM, ORNITHOGALUM, PHYTOLACCA, PITUITARUM, PLACENTA, SINAPIS ARV FLOS, QUERCUS GLAND SP, QUERCUS ROB | Temple Health Nutrition, LLC | d54bb860-560c-4f8f-9aea-a0b7774cc92b | 2021-12-29 | Warnings | C151H8M554 |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | XF417D3PSL | |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Warm Ivory | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 97e7ece8-a705-4988-ba52-6d3f11573521 | 2021-12-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.